Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shortening antibiotic treatment for asymptomatic bacteriuria after kidney transplant
NCT02575495Phase 2Completed
- Sponsor
- Mahidol University
- Start
- Feb 2015
- Primary completion
- Jan 2016
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in asymptomatic bacteriuria (ASB), sponsored by Mahidol University. Primary endpoint: Composite end point of Symptomatic urinary tract infection, Sepsis, Graft function and Mortality rate at 1 month. Started Feb 2015; status: completed.
02
Conditions
asymptomatic bacteriuria (ASB)
Beyond the preview
Go deeper on NCT02575495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02575495.